714 results match your criteria Augmentation Cystoplasty


Pregnancy and delivery after augmentation cystoplasty: A case report and review of literature.

World J Clin Cases 2022 May;10(13):4177-4184

Department of Urology, West China Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China.

Background: Augmentation cystoplasty, first described by Mikulicz in 1899 involves segments of bowel, stomach or mega-ureter to increase bladder capacity in those with inadequate bladder function or lack of detrusor compliance. The most widely used bowel segment is a detubularised patch of ileum. When ileum is not suitable for augmentation, sigmoid colon is the alternative. Read More

View Article and Full-Text PDF

Application of urodynamics combined with contrast-enhanced ultrasound in evaluation of the urinary tract in patients with low bladder compliance and vesicoureteric reflux who underwent bladder augmentation alone.

Kaohsiung J Med Sci 2022 May 24. Epub 2022 May 24.

Department of Urology, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China.

We assessed the use of common urodynamics (CUD) combined with contrast-enhanced ultrasound (CEUS) to investigate the efficacy and durability of sigmoid cystoplasty alone in patients with low bladder compliance associated with vesicoureteric reflux (VUR). In this study, we recruited 25 patients with low bladder compliance and VUR who underwent bladder augmentation without antireflux surgery at our institutions between June 2017 and June 2021. The bladder condition and VUR grade were assessed preoperatively and postoperatively via CUD combined with CEUS. Read More

View Article and Full-Text PDF

Efficacy of complete laparoscopic ileal augmentation cystoplasty for the treatment of low bladder capacity and compliance: a case series.

BMC Urol 2022 Apr 12;22(1):58. Epub 2022 Apr 12.

Department of Urology, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230032, Anhui, China.

Objectives: To investigate the safety and efficacy of complete laparoscopic ileal augmentation cystoplasty for the treatment of low bladder capacity and compliance.

Methods: The clinical data of 13 patients with low bladder capacity and compliance were retrospectively analyzed. Therapeutic efficacy was evaluated at follow-up. Read More

View Article and Full-Text PDF

Efficacy of pembrolizumab in a rare type of bladder cancer arising 25 years after augmentation cystoplasty.

BMJ Case Rep 2022 Mar 30;15(3). Epub 2022 Mar 30.

Urology, Juntendo University, Graduate School of Medicine, Bunkyo-ku, Tokyo, Japan

We report using the checkpoint inhibitor, pembrolizumab, as part of a multimodal treatment plan in a 36-year-old man with a rare bladder cancer arising 25 years after augmentation cystoplasty (sigmoid colonic cystectomy for neuropathic bladder was performed at 9 years old). On a regular clinic visit for clean intermittent catheterisation, the patient presented with gross haematuria and was diagnosed with urothelial carcinoma with sarcomatoid change. Gemcitabine and cisplatin-based neoadjuvant chemotherapy was unsuccessful, and pembrolizumab infusions (200 mg every 3 weeks) were initiated. Read More

View Article and Full-Text PDF

Ureteral reimplantation during augmentation cystoplasty is not needed for vesicoureteral reflux in patients with neurogenic bladder: a long-term retrospective study.

BMC Urol 2022 Mar 29;22(1):48. Epub 2022 Mar 29.

Department of Renal and Genitourinary Surgery, Graduate School of Medicine, Hokkaido University, North-15 West-7 Kita-Ku, Sapporo, 060-8638, Japan.

Background: To investigate the need for ureteral reimplantation for vesicoureteral reflux (VUR) during augmentation cystoplasty (AC) in the long term.

Methods: A total of 19 patients with a median age at surgery of 14 years (3-38 years) who underwent AC for neurogenic bladder with VUR between 1983 and 2016 were included in this study. The changes in VUR grade and urodynamic findings were retrospectively evaluated. Read More

View Article and Full-Text PDF

Augmentation cystoplasty in dogs: A comparative study of different tunica vaginalis grafts.

Vet Anim Sci 2022 Jun 18;16:100247. Epub 2022 Mar 18.

Department of Surgery, Anesthesiology and Radiology, Faculty of Veterinary Medicine, Suez Canal University, 4.5 Ring Road, Ismailia, 41522, Egypt.

In veterinary practice, numerous urological disorders that cause bladder dysfunction necessitate augmentation cystoplasty (AC). The purpose of this study is to evaluate the dog tunica vaginalis allograft (DTVA), sheep tunica vaginalis xenograft (STVX) and sheep tunica vaginalis decellularized extracellular matrix (STVDEM) as graft materials for urinary bladder (UB) reconstruction following a 45±5% cystectomy model in dogs. In this study, 18 adult apparently healthy mongrel dogs of both sexes were divided into three groups (6 dogs each): the DTVA group, the STVX group, and the STVDEM group. Read More

View Article and Full-Text PDF

Commentary on "cost comparison of intra-detrusor injection of botulinum toxin versus augmentation cystoplasty for refractory neurogenic detrusor overactivity in children".

J Pediatr Urol 2022 Jun 4;18(3):320. Epub 2022 Mar 4.

The Sydney Childrens Hospital Network, Westmead, NSW 2145 Australia. Electronic address:

View Article and Full-Text PDF

Cost comparison of intra-detrusor injection of botulinum toxin versus augmentation cystoplasty for refractory neurogenic detrusor overactivity in children.

J Pediatr Urol 2022 Jun 8;18(3):321-322. Epub 2022 Mar 8.

Institute for Pediatric Urology, New York Presbyterian Hospital, Weill Cornell Medical College, New York, NY, USA. Electronic address:

View Article and Full-Text PDF

Long-term urology outcomes of anorectal malformation.

J Pediatr Urol 2022 Apr 7;18(2):150.e1-150.e6. Epub 2022 Feb 7.

Department of Paediatric Urology, Evelina London Children's Hospital, Westminster Bridge Road, London, SE1 7EH, United Kingdom; Kings College London, London, United Kingdom.

Introduction: Urological problems are a recognised feature of anorectal malformation (ARM). Previous assumptions of favourable long-term urinary outcomes are being challenged.

Objective: We hypothesised that urinary tract problems are common in ARM and frequently persist into adulthood. Read More

View Article and Full-Text PDF

Supratrigonal cystectomy and augmentation cystoplasty with ileum or ileocecum in the treatment of ulcerative interstitial cystitis/bladder pain syndrome: a 14-year follow-up.

Int Urogynecol J 2022 May 1;33(5):1267-1272. Epub 2022 Mar 1.

Department of Urology and Pediatric Urology, University Hospital of Muenster, Albert Schweitzer Campus 1, 48149, Muenster, Germany.

Introduction And Hypothesis: This study analyzes the long-term results of supratrigonal cystectomy and augmentation cystoplasty in patients with severe ulcerative interstitial cystitis/bladder pain syndrome (IC/BPS) and reduced bladder capacity.

Methods: Outcome data were retrospectively and prospectively collected and analyzed in women who underwent supratrigonal cystectomy and augmentation cystoplasty for ulcerative IC/BPS at Muenster University Hospital between 1991 and 2006. We used cross-tabulation and Pearson's Chi-squared test to examine how outcome is influenced by age, preoperative functional bladder volume, and choice of augmentation material. Read More

View Article and Full-Text PDF

Cost comparison of intra-detrusor injection of botulinum toxin versus augmentation cystoplasty for refractory neurogenic detrusor overactivity in children.

J Pediatr Urol 2022 Jun 7;18(3):314-319. Epub 2022 Feb 7.

Institute for Pediatric Urology, New York Presbyterian Hospital, Weill Cornell Medical College, New York, NY, USA. Electronic address:

Introduction: Treatment options for refractory neurogenic detrusor overactivity (NDO) in children include botulinum toxin type A (BTX-A) and augmentation cystoplasty (AC). Although BTX-A is accepted in contemporary pediatric urologic practice, cost and long-term outcomes data for BTX-A are limited relative to the gold standard, AC. The purpose of this study was to compare the projected 10-year costs of AC versus BTX-A. Read More

View Article and Full-Text PDF

An adapted enhanced recovery protocol for adult augmentation cystoplasty in limited sources countries: A pilot clinical trial.

Turk J Urol 2021 Nov;47(6):509-517

Research Center for Evidence Based-Medicine, Iranian EBM Center: A Joanna Briggs Institute Center of Excellence, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Urology, Tabriz University of Medical Sciences Faculty of Medicine, Tabriz, Iran.

Objective: To investigate an adapted enhanced recovery after surgery (ERAS) protocol in adult augmentation cystoplasty (AC).

Material And Methods: A total of 33 consecutive cases with a history of refractory idiopathic detrusor overactivity (IDO) or neurogenic bladder (NGB) with low capacity, poor compliance, high sustained detrusor pressure, and whose previous therapeutic methods had failed were enrolled. The adapted ERAS fasting8 hours, high protein, low carbohydrate diet, antibiotics, did not use narcotics as much as possible during anesthesia, acetaminophen, early nasogastric tube removal, neostigmine injection postoperation, metoclopramide, early oral diet, and mobilization were applied, and morbidity and hospital stay duration were analyzed. Read More

View Article and Full-Text PDF
November 2021

Hemi-Kock Continent Stoma With Augmentation Cystoplasty: Modifications and Outcomes.

Urology 2022 Feb 12;160:217-222. Epub 2021 Dec 12.

Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.

Objective: To evaluate the long-term outcomes and impact of surgical modifications on the need for secondary surgery of the Hemi-Kock continent catheterizable stoma, comprising a detubularized ileal segment with an attached stapled ileoileal intussusception of the catheterizable channel, in patients with complex lower urinary tract disorders. The technique may be used for augmentation in patients with reduced bladder capacity who require a continent catheterizable channel. Compared to the flap and ileocecal valve procedures, the hemi-Kock technique has not been widely adopted. Read More

View Article and Full-Text PDF
February 2022

Bladder exstrophy: We need to improve. A lot.

J Pediatr Urol 2022 02 15;18(1):38.e1-38.e11. Epub 2021 Nov 15.

Division of Urology, Sidra Medicine, Doha, Qatar.

Introduction: Bladder exstrophy (BE) affects continence and sexual function, impacting on social life and mental health. Long-term data from the patients' point of view are needed to get a real-life perspective on the problem.

Study Design: A self-developed questionnaire concerning sexual, psychosexual and psychosocial outcomes was sent to the adult members of the Brazilian Exstrophy Group. Read More

View Article and Full-Text PDF
February 2022

Augmentation uretero-enterocystoplasty for refractory urinary tract dysfunction: a long-term retrospective study.

BMC Urol 2021 Nov 30;21(1):166. Epub 2021 Nov 30.

Department of Urology, Beijing Boai Hospital, China Rehabilitation Research Centre; School of Rehabilitation of Capital Medical University, No 10. Jiaomen Beilu, Fengtai District, Beijing, 100068, China.

Objectives: To report the long-term efficacy and complications of the augmentation uretero-enterocystoplasty (AUEC), including augmentation cystoplasty with simultaneous ureteroplasty and ureteral anti-reflux implantation in a single center.

Methods: We retrospectively reviewed clinical records, video-urodynamic data, and magnetic resonance urography of 210 patients who underwent the procedure for refractory lower urinary tract dysfunction (LUTD) from 2003 to 2019. International vesicoureteral reflux (VUR) and upper urinary tract dilatation (UUTD) grading systems were applied to assess upper urinary tract function, and post-operative complications were assessed. Read More

View Article and Full-Text PDF
November 2021

Secondary malignancy after urologic reconstruction procedures: a multi-institutional case series.

Hum Pathol 2022 01 19;119:69-78. Epub 2021 Nov 19.

Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, 37232, USA. Electronic address:

Urinary diversion and reconstructive urologic procedures are most often performed by incorporating various intestinal segments into the urinary tract. Although the risk of malignancy, among other complications, is well recognized and occurs most frequently after ureterosigmoidostomies and cystoplasties, data on the histopathologic and immunohistochemical characteristics of these tumors are scant. This study aims to evaluate the clinicopathological features of secondary tumors arising after urologic reconstruction procedures. Read More

View Article and Full-Text PDF
January 2022

Overactive bladder: A review and update.

Exp Ther Med 2021 Dec 14;22(6):1444. Epub 2021 Oct 14.

Department of Fundamental, Prophylactic and Clinical Disciplines, Faculty of Medicine, 'Transilvania' University of Brasov, 500019 Brasov, Romania.

Overactive bladder syndrome is a chronic, disabling condition with physical, psychological and social consequences that significantly affects the quality of life of millions of patients worldwide. The economic impact of this disorder is crucial. Overactive bladder syndrome is a little-known condition, with different manifestations from patient to patient, which causes a great deal of frustration to the medical staff involved. Read More

View Article and Full-Text PDF
December 2021

Update on the management of overactive bladder.

Ther Adv Urol 2021 Jan-Dec;13:17562872211039034. Epub 2021 Aug 31.

Bristol Urological Institute, Southmead Hospital, Bristol, Somerset, UK.

Overactive bladder (OAB) syndrome is a common condition characterised by urinary urgency, with or without urgency incontinence, frequency and nocturia, in the absence of any other pathology. Clinical diagnosis is based upon patient self-reported symptomology. Currently there is a plethora of treatments available for the management of OAB. Read More

View Article and Full-Text PDF

Experimental Studies of Latissimus Dorsi Detrusor Myoplasty for Bladder Acontractility: A Systematic Review.

Plast Surg Nurs 2021 Jul-Sep 01;41(3):159-162

Antonio Jorge Forte, MD, PhD, is a plastic surgeon at the Division of Plastic Surgery, Mayo Clinic, Jacksonville, FL.

Current therapies that allow patients with bladder acontractility to void are limited. The standard therapy is clean intermittent catheterization. Latissimus dorsi detrusor myoplasty (LDDM) has been shown to provide functional contraction and allow patients with bladder acontractility to void voluntarily. Read More

View Article and Full-Text PDF
October 2021

Bladder augmentation from an insider's perspective: a review of the literature on microcirculatory studies.

Int Urol Nephrol 2021 Nov 25;53(11):2221-2230. Epub 2021 Aug 25.

Institute of Surgical Research, University of Szeged, Pulz u. 1., Szeged, 6724, Hungary.

Augmentation cystoplasty is an exemplary multiorgan intervention in urology which is particularly associated with microvascular damage. Our aim was to review the available intravital imaging techniques and data obtained from clinical and experimental microcirculatory studies involving the most important donor organs applied in bladder augmentation. Although numerous direct or indirect methods are available to assess the condition of microvessels the implementation of microcirculatory diagnostic methods in humans is still challenging and the assessment of organ microcirculation in the operating theatre has limitations. Read More

View Article and Full-Text PDF
November 2021

Current Applications and Future Directions of Bioengineering Approaches for Bladder Augmentation and Reconstruction.

Front Surg 2021 18;8:664404. Epub 2021 Jun 18.

Department of Urology, China Rehabilitation Research Center, Rehabilitation School of Capital Medical University, Beijing, China.

End-stage neurogenic bladder usually results in the insufficiency of upper urinary tract, requiring bladder augmentation with intestinal tissue. To avoid complications of augmentation cystoplasty, tissue-engineering technique could offer a new approach to bladder reconstruction. This work reviews the current state of bioengineering progress and barriers in bladder augmentation or reconstruction and proposes an innovative method to address the obstacles of bladder augmentation. Read More

View Article and Full-Text PDF

Revascularized Pyelo-Uretero-Cystoplasty in Patients with Chronic Bladder Outlet Obstruction Due to Ectopic Ureterocele: A Safe Surgical Technique with Superior Continence Outcomes.

J Invest Surg 2022 Apr 17;35(4):737-744. Epub 2021 Jun 17.

Pediatric Urology and Regenerative Medicine Research Center, Section of Tissue Engineering and Stem Cells Therapy, Children's Hospital Medical Center, Tehran University of Medical Sciences, Tehran, Iran.

Purpose: To present the outcomes of revascularized pyeloureterocystoplasty with ureterocele unroofing in end stage bladder patients with duplex system and ureterocele.

Methods: Thirteen patients with obstruction of intrauterine outlet from an ectopic obstructive ureterocele were included. Fourteen units of duplex systems underwent upper pole partial nephrectomy in conjunction with augmentation revascularized pyeloureterocystoplaty and ureterocele unroofing. Read More

View Article and Full-Text PDF

Outcomes of pregnancy and delivery in women with continent lower urinary tract reconstruction: systematic review of the literature.

Int Urogynecol J 2021 07 14;32(7):1707-1717. Epub 2021 Jun 14.

Department of Urology, CHU-Université de Nantes, 1 place Alexis Ricordeau, 44000, Nantes, France.

Introduction And Hypothesis: The aim of this systematic review of the literature was to pool all the existing data regarding pregnancy and delivery in women with neurogenic bladder or bladder exstrophy who had undergone previous lower urinary tract reconstruction (LUTR).

Methods: We conducted a systematic review of the literature from PubMed/MedLine, ClinicalTrials.gov and the Google Scholar database, from 1972 to July 2020. Read More

View Article and Full-Text PDF

Regeneration of muscular wall of the bladder using a ureter matrix graft as a scaffold.

Biotech Histochem 2022 Apr 10;97(3):207-214. Epub 2021 Jun 10.

Pediatric Urology and Regenerative Medicine Research Center, Section of Tissue Engineering and Stem Cells Therapy, Children's Hospital Medical Center, Tehran University of Medical Sciences, Tehran, Iran.

We investigated a method for bladder augmentation in rats using a decellularized ureter graft. We used 16 rats divided into two groups of eight. After partial cystectomy, the bladders in group 1 were grafted with a 1 cm patch of human decellularized ureter. Read More

View Article and Full-Text PDF

Long-term effectiveness and safety of bladder augmentation in spina bifida patients.

Neurourol Urodyn 2021 08 3;40(6):1576-1584. Epub 2021 Jun 3.

Department of Urology, San Juan University Hospital, Alicante, Spain.

Aims: To establish the long-term efficacy and safety of bladder augmentation in spina bifida patients.

Material And Methods: Sixteen patients were operated on using the Bramble technique. Preoperative and postoperative evaluation included clinical history, blood tests, urine cultures, cystography, pyelography, ultrasound, and filling cystometry. Read More

View Article and Full-Text PDF

Management of neurogenic bladder dysfunction in children update and recommendations on medical treatment.

Int Braz J Urol 2022 Jan-Feb;48(1):31-51

Service of Urology, Italian Hospital, Buenos Aires, Argentina.

Introduction: Defective closure of the neural tube affects different systems and generates sequelae, such as neurogenic bladder (NB). Myelomeningocele (MMC) represents the most frequent and most severe cause of NB in children. Damage of the renal parenchyma in children with NB acquired in postnatal stages is preventable given adequate evaluation, follow-up and proactive management. Read More

View Article and Full-Text PDF
December 2021

Complication profile of augmentation cystoplasty in contemporary paediatric urology: a 20-year review.

ANZ J Surg 2021 05 12;91(5):1005-1010. Epub 2021 Apr 12.

Department of Paediatric Urology, Royal Children's Hospital, Melbourne, Victoria, Australia.

Background: The aim of this study was to describe the complication profile of augmentation cystoplasty in contemporary paediatric urology as well as its effect on bladder metrics.

Methods: Consecutive operative cases were retrospectively reviewed at a single institution over 20 years (1999-2019). Short- and long-term outcomes and complications following augmentation cystoplasty were defined. Read More

View Article and Full-Text PDF

The Effect of Sacral Neuromodulation in Ambulatory Spina Bifida Patients with Neurogenic Bladder and Bowel Dysfunction.

Urology 2021 07 6;153:345-350. Epub 2021 Feb 6.

Department of Urology, China Rehabilitation Research Center, Beijing China; Department of Urology, Capital Medical University, Beijing China.

Objective: To assess the effect of sacral neuromodulation (SNM) in ambulatory spina bifida patients with neurogenic bladder and bowel dysfunction.

Materials And Methods: We retrospectively reviewed the records of 29 ambulatory spina bifida patients with neurogenic bladder and bowel dysfunction who underwent SNM testing from July 2012 to January 2020. Clinical data and video-urodynamic parameters were collected and compared using the t-test and the chi-square test. Read More

View Article and Full-Text PDF

Paediatric cystolitholapaxy using mini PCNL-kit through the Mitrofanoff stoma.

Ann Med Surg (Lond) 2021 Feb 15;62:88-91. Epub 2021 Jan 15.

Department of Urology, Tahar Sfar Mahdia, 5100, Tunisia.

Bladder stones are a common complication after augmentation cystoplasty and urinary diversion. However, the treatment of recurrent cystolithiasis in neuropathic children remains a real challenge for urologists and open procedures may be associated with significant morbidity. Currently, mini-invasive management options are available in the therapeutic armamentarium. Read More

View Article and Full-Text PDF
February 2021